Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Asset Utilization Ratio (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.83 as the latest value for Q3 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 41.37% to 0.83 in Q3 2025 year-over-year; TTM through Sep 2025 was 0.83, a 41.37% decrease, with the full-year FY2024 number at 1.27, up 411.88% from a year prior.
  • Asset Utilization Ratio was 0.83 for Q3 2025 at bioAffinity Technologies, down from 1.49 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.49 in Q2 2025 to a low of 0.03 in Q1 2023.
  • A 4-year average of 0.71 and a median of 0.72 in 2024 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: soared 39727.83% in 2024, then plummeted 41.37% in 2025.
  • bioAffinity Technologies' Asset Utilization Ratio stood at 0.03 in 2022, then surged by 1012.16% to 0.28 in 2023, then surged by 420.91% to 1.43 in 2024, then tumbled by 41.97% to 0.83 in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Asset Utilization Ratio are 0.83 (Q3 2025), 1.49 (Q2 2025), and 1.46 (Q1 2025).